Genmab — Januar 2015
-
Dara studierne is recruiting like a rocket
-
har jeg lige fået at vide af jannsen siger jan
det stemmer godt overens med de rygter der er i markedet om at de 500 patient studier vil blive færdigindrullet i år ! -
og revlimid phase III skulle vidst være t´æt på Q1-Q2 at være færdigindrullet
-
CR North of 40% 1
-
ingen toxic problemer i TF-ADC
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Nogen som ved hvorfor vi endte op med et fald på en plusdag, Deutche hæver mål, samt kraftig dollarstigning - havde faktisk troet vi røg over 400. Men jeg er også blevet lidt hyper på det sidste